Dr Martin Forster, Consultant Medical Oncologist
Dr Martin Forster
Consultant Medical Oncologist
Dr Martin Forster MBBS, FRCP, PhD
Consultant Medical Oncologist
Dr Martin Forster
Consultant Medical Oncologist MBBS, FRCP, PhD
Dr Forster is a recommended Consultant Medical Oncologist
Areas of expertise
- Medical oncology
- Lung cancer
- Head and neck cancer
- Thoracic cancer
- Chemotherapy
Recommendations for Dr Forster
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
byDr Diana Maria Davenport, GP
❝Keen researcher in novel treatment and also has good patient rapport❞
byDr Diana Maria Davenport, GP
❝Keen researcher in novel treatment and also has good patient rapport❞
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
About Dr Martin Forster
GMC number: 4129392
Year qualified: 1994
Place of primary qualification: University of Newcastle upon Tyne
Areas of expertise
- Thoracic oncology
- Head oncology
- Neck oncology
Professional memberships
Articles by Dr Martin Forster
Study protocol for the saron trial: a multicentre, randomised controlled phase trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
Fc-optimized anti-cd25 depletes tumor-infiltrating regulatory t cells and synergizes with pd-1 blockade to eradicate established tumors
Antitumor activity of lurbinectedin (pm01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase i study
Phase 1/2a trial of intravenous bal101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours
Guidance by molecular selection improves the outcome of early phase treatment for gynecological (gyn) cancers
Allele-specific hla loss and immune escape in lung cancer evolution
Tracking the evolution of non–small-cell lung cancer
